1. Bienes raíces

Instituto Nacional de Cancerología, SS
Zona de Hospitales, Tlalpan, México DF
www.medicalrp.us
Comité Científico:
Dr. Jaime de la Garza Salazar (Presidente)
Dra. Aura Erazo Valle Solís (Vice –presidente)
Coordinadores de Módulo: Dra. Guadalupe Cervantes
CMN 20 de Noviembre, ISSSTE
Dr. Enrique Bargalló
INCan, SS
Dr. Ricardo Villalobos
CMN La Raza, IMSS
Dr. Alejandro Silva
CMN Siglo XXI, IMSS
Dr. Fernando Lara
INCan, SS
Dr. Sergio Rodríguez
FUCAM, SS
Dra. Adela Poitevin
Asoc. Mex. De Mastología
Dr. Miguel Lázaro
Hospital General de México, SS
Profesores Extranjeros: Dra. Mariana Chávez
M D Anderson, Tx. USA
www.medicalrp.us
Ponentes Nacionales: Dr. Aldaco Fernando Dr. Alvarado Alberto Dra. Arce Claudia Dra. Cabrera Paula Dra. Cortes Patricia Dra. Flores ChrisSan Dr. Flores Noé Dra. Garnica Georgina Dra. Gerson Raquel Dr. Juárez Alejandro Dr. Maffuz Antonio Dr. Magallanes Manuel Dr. Mainero Fernando Dra. Murillo Karina Dra. Poitevin Adela Dr. Quintana Miguel Dr. Rivera Samuel Dr. Robles Jorge Dra. Ruiz Erika Dra. Torrecillas Laura Dra. Tusie Teresa Dra. Villavicencio Michelle CMN 20 de Nov INCan INCan ISSEMYM CMN 20 de Nov INCMNSZ 1o de Octubre Hosp Gral de Mex Hosp. ABC CMN 20 de Nov FUCAM Militar IMSS Zaragoza Asoc Mex Mastología H. Naval CMN Siglo XXI PEMEX INCan CMN 20 de Nov INCMNSZ CMN 20 de Nov www.medicalrp.com.mx
Jueves&26&de&Febrero
09:00
Inauguración
09:15
Dr M Quintana
Hosp. Naval
09:30
Dr Fdo Aldaco
CMN 20 de Nov.
09:45
10:10
Inmunotherapeutic&approaches&to&breast&cancer
Introduction to
Inmunotherapy
Dra.&Georgina&Garnica&&
HOSPITAL&GENERAL
Dra.&Mariana&Chavez&
MD&ANDERSON&
Houston&TX.
11:55
12:10
12:25
12:40
12:55
Coordinadora
Dra Cervantes
CMN 20 de Nov.
Targeting&epigenetics&in&Breast&Cancer:&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
Clinical&implications
Inmune&checkpoints&and&cancer&therapy
SYMPOSIA&ESTRATEGIAS&EN&RESISTENCIA&A&
HORMONOTERAPIA&EN&CANCER&DE&MAMA&
11:10
11:40
Dr. Abelardo Meneses, Director General del INCan
CHAIRMAN: Dr. Jaime de la Garza, INCan
CO- CHAIRMAN Dra Aura Erazo, CMN 20 de Noviembre
Dr. Sergio Rodíiguez , Director FUCAM
Dr José L Barrera, Director COE ISSEMYM
COFFEE&BREAK
Dr. Antonio Maffuz
FUCAM
The impact of patient perspective on outcomes in
breast reconstruction
Dr Jorge Robles QoL in Breast
Reconstruction
PEMEX
Reconstruction for the high risk patient: challenges
of chemotherapy, radiation therapy and patient
selection
Delayed and immediate partial breast reconstruction
after breast conserving surgery
Dr Fdo. Mainero
IMSS
Mechanisms of HER2 signaling, targeting, and
resistance
Dr Samuel Rivera
CMN Siglo XXI
Dra. Claudia Arce HER2 Positive
INCAN
Breast Cancer
Dr. Alejandro
Juárez
CMN 20 de Nov.
Neoadjuvant therapy in HER2 positive breast cancer,
Coordinador
latest developments and biomarkers and how it
Dr. Ricardo Villalobos
serves as a discovery platform
CMN LA RAZA IMSS
Management of metastatic HER2 positive disease:
optimizing current therapies and an overview of
new agents in development
13:10
Round&Table&&Speakers&&&Coordinators
13:35
13:50
14:05
14:20&a&
15:00
&Dr.&Alberto&Alvarado&&
INCAN
Neoadjuvant&
Dra.&Erika&Ruiz&&&&&&& Treatment&of&
INCAN&
Dra Paula Cabrera
ISSEMYN Toluca
Coordinador
Dr Enrique Bargalló
INCAN
ER+&Breast&
Cancer
Coordinador
Dr. Alejandro Silva
CMN XXI IMSS
Clinical insights on the neoadjuvant therapy of ER+
breast cancer
Biomarkers for clinical management and research
Integration&of&Novel&targeted&agents&with&endocrine&therapy
Dra.&T.&Tusie,&INCMNSZ&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
Biomarcadores&para&el&manejo&clínico&de&cáncer&de&mama
Dra.&R&Gerson,&ABC
Coordinador&&&&&&&&&
Dr.&Fernando&Lara&&&&
INCAN&
Viernes+27+de+Febrero++
09:00
09:15
Adherence and persistence with adjuvant
aromatase inhibitor therapy
Dr Manuel
Magallanes
Hosp. MILITAR
Coordinador
Breast
Dra Karina Murillo
Dr Sergio
Second
primary
cancers
among
breast
cancer
Cancer
Hosp ZARAGOZA
Rodríguez Cuevas
Survivorship
survivors: Incidence and risk factors
ISSSTE
FUCAM
09:30
Round&Table&&Speakers&&&Coordinators
09:45
Estudios+CLEOPATRA++/+EMILIA+
10:45
11:!5
11:30
COFFEE+BREAK
Dra+Adela+Poitevin++++++++++++++++++++++++++
Med.+Sur
Dra Christian
Flores
INCMNSZ
11:45
New+Insights+
in++++++Breast+
Radiation
Dra Michelle
Villavicencio
CMN 20 de Nov.
Adapting+evidence+based+radiotherapy+to+
countries+with+limited+resources
Which patients can safely avoid radiation
after breast conserving surgery?
Coordinadora
Dra Adela Poitevin
Asoc. Mex. De
Mastología
What have we learned from the randomized
trials of partial breast RT?
12:00
Round+Table++Speakers+&+Coordinators
12:30
Dr+Noe+Flores+++++++++++++++++++
The clinical significance of heterogeneity in
HG+1+de+Octubre
triple negative breast cancer
Triple+Negative+++++
Breast+Cancer
12:45
Dra+Patricia+Cortes++++++++++++++++
CMN+20+de+Nov.
13:00
13:30
14:HRS
Adjuvant and neoadjuvant therapy: Current
practice and future approaches
Coordinador&&&&&&&&&
Dr&Miguel&Lázaro&&&&&
Hosp.&Gral&de&
México&
Round&Table&&Speakers&&&Coordinators
Dra+Laura+Torrecillas++
Pte+de+SMEO
Estado+actual+de+la+terapia+del+ca+de+mama++en+México
CLAUSURA+DR+JAIME+DE+LA+GARZA,+DRA+LAURA+TORRECILLAS,+DRA+.+AURA+ARGENTINA+ERAZO+VALLE+SOLIS
“LIDERES EN PROGRAMAS DE EDUCACION MEDICA CONTINUA” Contacto: 5350-7256 [email protected]
www.medicalrp.com.mx